Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Topical Cidofovir for Treatment of Resistant Viral Infections

Author(s):  McElhiney Linda F

Issue:  Sep/Oct 2006 - Dermatology
View All Articles in Issue

Page(s):  324-328

Topical Cidofovir for Treatment of Resistant Viral Infections Page 1
Topical Cidofovir for Treatment of Resistant Viral Infections Page 2
Topical Cidofovir for Treatment of Resistant Viral Infections Page 3
Topical Cidofovir for Treatment of Resistant Viral Infections Page 4
Topical Cidofovir for Treatment of Resistant Viral Infections Page 5

Download in electronic PDF format for $65

Abstract:  Cidofovir is a broad-spectrum antiviral agent with activity against several DNA viruses. An application to approve the use of topical cidofovir for acyclovir-resistant herpes virus infection was denied by the US Food and Drug Administration owing to the lack of phase III clinical trial data. The manufacturer stated that, as of 1997, no further controlled studies were planned or in progress to evaluate topical cidofovir in herpes simplex infections. It is unknown whether there are plans to conduct controlled studies of topical cidofovir for HPV or MVC infections. However, numerous case reports and published studies describe successful use of topical cidofovir to treat resistant and severe forms of viral infections such as molluscum contagiosum, condylomata acuminata, verruca vulgaris, herpes simplex virus infection, genital warts, and gingival infection with human papillomavirus. Because of the mutagenic properties of cidofovir, compounding the preparation is considered hazardous. Since most retail pharmacies

Related Keywords: Linda F. McElhiney, PharmD, RPh, cidofovir, antiviral agent, viral infections, topical preparations, antimicrobial resistance, molluscum contagiosum, condyloma acuminata, verruca vulgaris, genital warts, human papillomavirus, herpes simplex, CMV, cytomegalovirus retinitis, formulations

Related Categories: DERMATOLOGY, FORMULATIONS, LEGAL, WOUND CARE, DOSAGE FORMS/DRUG CARRIERS, INFECTIOUS DISEASE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Topical Cidofovir for Treatment of Resistant Viral Infections
McElhiney Linda F
Sep/Oct 2006
Pg. 324-328

Sensitization Therapy for Warts
Kuntz Rachael
Jul/Aug 2003
Pg. 266-270

Basics of Compounding for the Treatment of Warts
Allen Loyd V Jr
Mar/Apr 2004
Pg. 126-129

Valacyclovir 50-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2006
Pg. 461

Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312

Foscarnet Sodium 24-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2012
Pg. 336

Cidofovir 0.2-mg/mL Intravitreous Injection
Allen Loyd V Jr
Nov/Dec 2009
Pg. 554

Case Report of a Human Papillomavirus Infection Treated with Green Tea Extract and Curcumin Vaginal Compounded Medications
Agbi Kelechi E
, Hover Sara, Carvalho Maria
May/Jun 2018
Pg. 196-202

Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations
McElhiney Linda F
Jul/Aug 2013
Pg. 307-311

Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications
Agbi Kelechi E
, Carvalho Maria, Phan Ha, Tuma Cristiane
Jan/Feb 2017
Pg. 22-27

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions